Afya (NASDAQ:AFYA – Get Free Report) posted its earnings results on Wednesday. The company reported $0.36 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.37 by ($0.01), FiscalAI reports. Afya had a return on equity of 17.58% and a net margin of 20.55%. The firm had revenue of $190.16 million for the quarter, compared to analysts’ expectations of $190.28 million.
Afya Price Performance
Shares of NASDAQ AFYA traded down $0.40 during trading on Thursday, hitting $10.33. The company had a trading volume of 190,763 shares, compared to its average volume of 191,277. The firm has a market capitalization of $968.16 million, a price-to-earnings ratio of 6.30, a price-to-earnings-growth ratio of 1.69 and a beta of 0.43. The stock has a fifty day simple moving average of $13.00 and a two-hundred day simple moving average of $14.05. The company has a quick ratio of 2.20, a current ratio of 2.20 and a debt-to-equity ratio of 0.39. Afya has a fifty-two week low of $9.66 and a fifty-two week high of $16.16.
Analyst Ratings Changes
Several equities analysts recently weighed in on the company. Citigroup upgraded Afya from a “neutral” rating to a “buy” rating and cut their price target for the company from $16.00 to $12.00 in a research note on Tuesday, November 3rd. Wall Street Zen upgraded Afya from a “hold” rating to a “buy” rating in a research report on Sunday. Zacks Research lowered Afya from a “hold” rating to a “strong sell” rating in a report on Tuesday, November 3rd. Morgan Stanley raised Afya from an “underweight” rating to an “equal weight” rating and set a $12.60 price objective on the stock in a report on Thursday, November 5th. Finally, Bradesco Corretora upgraded Afya to an “outperform” rating and set a $17.00 price objective for the company in a research report on Thursday, September 24th. Four equities research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and two have issued a Sell rating to the company. According to data from MarketBeat, Afya presently has an average rating of “Hold” and a consensus price target of $15.18.
Check Out Our Latest Research Report on Afya
Insider Buying and Selling at Afya
In related news, insider Santos Welder Ferreira sold 4,161 shares of the company’s stock in a transaction dated Monday, October 5th. The shares were sold at an average price of $13.30, for a total transaction of $55,341.30. Following the completion of the transaction, the insider owned 35,000 shares in the company, valued at $465,500. This represents a 10.63% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 0.80% of the stock is currently owned by company insiders.
About Afya
Afya Limited is a Brazilian medical education and digital health company. Its education business offers undergraduate medical degree programs, medical residency preparation, postgraduate courses and continuing education for health professionals. The company also provides digital tools and services for medical students and practicing physicians, including clinical reference, practice-management and learning resources. These offerings support professionals at different stages of their medical careers.
Read More
- Five stocks we like better than Afya
- Checkmate for AI Chips? NVIDIA’s Crisis Opens the Board
- Can NVIDIA Maintain Its Momentum Without Huang?
- Six Flags Lost $366 Million in Q3—Its Insiders Just Went Shopping
- What Went Wrong With Amprius Technologies’ Q3? Less Than You’d Think
Receive News & Ratings for Afya Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Afya and related companies with MarketBeat.com's FREE daily email newsletter.
